Global EditionASIA 中文雙語Fran?ais
China
Home / China / Latest

Scientists should bolster defense against COVID-19 strains, senior biomedical engineer says

By Zhang Zhihao | chinadaily.com.cn | Updated: 2021-03-07 13:48
Share
Share - WeChat
Chen Wei, an academic at the Chinese Academy of Engineering, speaks during the second plenary meeting of the fourth session of the 13th National Committee of the Chinese People's Political Consultative Conference at the Great Hall of the People in Beijing, March 7, 2021. [Photo/Xinhua]

The country's scientific community should continue its rigorous and intensive research on COVID-19, and bolster the nation's preparedness by developing vaccines and diagnostic kits against mutated strains of SARS-CoV-2, a senior biomedical engineer said during the second plenary meeting of the fourth session of the 13th National Committee of the Chinese People's Political Consultative Conference on Sunday.

"History and practices have told us that only by grasping core technologies with our own hands can we ensure socioeconomic development, long-term prosperity and the stability of the nation, and safeguard people's lives and health," said Chen Wei, an academic at the Chinese Academy of Engineering and the lead scientist who spearheaded China's single-dose adenovirus vector vaccine against COVID-19.

The vaccine, dubbed "Ad5-nCoV", uses a weakened common cold virus to introduce a section of the genetic material from the novel coronavirus into the human body, thus training its immune system to recognize the virus and fight it off.

With a single injection, the vaccine has an overall efficacy rate of 65.7 percent at preventing symptomatic cases and is 90.98 percent effective in preventing severe disease, according to interim analysis of phase three human trials.

Current data shows that a single dose should provide protection for six months. If an individual were to receive a booster shot after the six months period, it can increase the immune response 10 to 20 times, and the two-shot regime is estimated to provide protection for two years.

On March 16, Ad5-nCoV was the first vaccine candidate against COVID-19 in the world to enter human trials. It was later green-lighted for emergency use in the Chinese military and has now been approved for conditional market use in China.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美h片在线观看| 中文字幕一二三区| 男人j桶进女人j的视频| 国产成人亚洲精品蜜芽影院| av成人免费电影| 日本19禁综艺直接啪啪| 亚洲伊人精品综合在合线| 神马伦理电影看我不卡| 国产免费小视频| 香蕉狠狠再啪线视频| 天天综合色天天综合网| 久久中文字幕无码专区| 樱桃视频高清免费观看在线播放| 亚洲色欲色欲综合网站| 老司机69精品成免费视频| 国产成人精品2021| 720lu国内自拍视频在线| 嫩b人妻精品一区二区三区| 久久亚洲AV成人无码| 欧美一区二区三区久久综合| 亚洲综合伊人久久大杳蕉| 精品国产香蕉伊思人在线又爽又黄| 无遮挡动漫画在线观看| 亚洲成a人片在线观看中文| 香蕉99国内自产自拍视频| 国产麻豆流白浆在线观看| 一本高清在线视频| 日本精品αv中文字幕| 亚洲国产视频一区| 色综合久久久久无码专区| 国产精品久久久久乳精品爆| a级毛片高清免费视频在线播放 | 被吃奶跟添下面视频| 日本三级黄色片网站| 亚洲一区二区三区影院| 污污污污污污www网站免费| 国产免费牲交视频| wwwxxx国产| 国产黄视频网站| selao久久国产精品| 成人欧美1314www色视频|